Risk adjusted net present value: What is the current valuation of Incyte’s Epacadostat?

Epacadostat is a small molecule commercialized by Incyte, with a leading Phase II program in Salivary Gland Cancer.

Handguns From Home Account for Most Adolescent School Shootings

School shootings perpetrated by adolescents have mainly used handguns, typically obtained from family members, a cross-sectional study showed. Among 253 adolescent school shootings from 1990

November 28, 2023

Is health a human right? The American College of Physicians answers with an emphatic YES!

The American College of Physicians asserts that health is a fundamental human right, advocating for US healthcare reforms that align with ethical obligations and human

November 2, 2023

Regeneron and Intellia expand partnership on CRISPR therapies

The partnership will utilise Regeneron’s antibody-targeted adeno-associated virus (AAV) vectors and delivery systems. Credit: lev radin/Shutterstock.com. Regeneron Pharmaceuticals has entered an expanded research collaboration with

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.